Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Jun 12, 2019 at 8:40 AM EDT

Big Biotechs Have Short Sellers on the Run

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The May 31 short interest data…

Chris Lange | Jun 12, 2019 at 8:30 AM EDT

Big Pharma Sees a Rising Tide in Short Interest

The May 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Jun 11, 2019 at 4:55 PM EDT

New Sickle Cell Disease Treatment Could Be a Blockbuster With $1 Billion in Sales

One relatively small clinical-stage biopharmaceutical player called Global Blood Therapeutics may be about to change how sickle cell disease treatment…

Chris Lange | Jun 11, 2019 at 10:10 AM EDT

Meet the Newest Treatment for Autism Using Cannabidiol

Zynerba Pharma has just announced that the U.S. Patent and Trademark Office has issued a patent for the firm’s treatment…

Chris Lange | Jun 11, 2019 at 9:55 AM EDT

Is CymaBay Therapeutics’ Liver Disease Trial Sunk?

CymaBay Therapeutics shares were nearly halved early Tuesday after the company provided an update from its midstage study of seladelpar…

Chris Lange | Jun 10, 2019 at 12:55 PM EDT

Why NovaBay Pharma Shares Absolutely Exploded

NovaBay shares absolutely exploded on Monday after the company announced that its eye care treatment would be readily available on…

Hristina Byrnes | Jun 10, 2019 at 10:39 AM EDT

Researchers Discover a Breakthrough Drug That May Significantly Delay Type 1 Diabetes

A monoclonal antibody called teplizumab has been shown to delay the onset of type 1 diabetes for as long as…

Chris Lange | Jun 10, 2019 at 10:30 AM EDT

How ReWalk Is Capitalizing on Its Big Win

ReWalkshares took a step back on Monday after the firm announced that it would be pricing a registered direct offering…

Paul Ausick | Jun 10, 2019 at 10:05 AM EDT

What Insys Therapeutics Gets by Filing for Chapter 11

Fentanyl-maker Insys Therapeutics has filed for bankruptcy protection while the company sells all its assets.

Chris Lange | Jun 6, 2019 at 1:35 PM EDT

5 ASCO Winners That Could Still More Than Double

24/7 Wall St. has taken a look at Wedbush’s recent ASCO roundup, and we’ve picked out a few of the…

Douglas A. McIntyre | Jun 6, 2019 at 7:07 AM EDT

Fake Health News Has Become So Common New Guidelines Now Help Recognize Them

The problem of fake news has spread to health news, which can be critical to the well being of millions…

Hristina Byrnes | Jun 5, 2019 at 12:42 PM EDT

The World’s Most Often Prescribed Drug Might Be Killing Us

Proton pump inhibitors (PPIs) — a widely prescribed group of medications that combat heartburn, GERD (gastroesophageal reflux disease), and ulcers…

Chris Lange | Jun 5, 2019 at 11:15 AM EDT

Is InflaRx Sunk by a Midstage Skin Condition Study?

InflaRx shares were destroyed on Wednesday after the firm announced results from its midstage trial in patients suffering from moderate…

Hristina Byrnes | Jun 5, 2019 at 11:11 AM EDT

Prices for Many Very Popular Prescription Drugs Have Soared Since 2012

Prices for dozens of popular prescription drugs increased, sometimes doubling in cost, over the five-year period from 2012 to 2017,…

Chris Lange | Jun 5, 2019 at 10:35 AM EDT

How ReWalk’s Exo-Suit Is Breaking the Mold for Stroke Survivors

ReWalk Robotics shares absolutely exploded on Wednesday on news that the FDA has cleared the firm's ReStore soft exo-suit system…

1 … 96 97 98 99 100 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Big Biotechs Have Short Sellers on the Run

Big Pharma Sees a Rising Tide in Short Interest

New Sickle Cell Disease Treatment Could Be a Blockbuster With $1 Billion in Sales

Meet the Newest Treatment for Autism Using Cannabidiol

Is CymaBay Therapeutics’ Liver Disease Trial Sunk?

Why NovaBay Pharma Shares Absolutely Exploded

Researchers Discover a Breakthrough Drug That May Significantly Delay Type 1 Diabetes

How ReWalk Is Capitalizing on Its Big Win

What Insys Therapeutics Gets by Filing for Chapter 11

5 ASCO Winners That Could Still More Than Double

Fake Health News Has Become So Common New Guidelines Now Help Recognize Them

The World’s Most Often Prescribed Drug Might Be Killing Us

Is InflaRx Sunk by a Midstage Skin Condition Study?

Prices for Many Very Popular Prescription Drugs Have Soared Since 2012

How ReWalk’s Exo-Suit Is Breaking the Mold for Stroke Survivors

Is Jeff Bezos’ New Startup An Even Bigger Idea than Amazon? He Tells CNBC it Will Drive ‘Civilizational Wealth.’

Cramer Calls Intel the “Number One Name” and “More Important Than NVIDIA.” The Stock Soars Today After a Massive Double Upgrade.

‘I Feel Like It’s 1999 Again.’ CNBC Analyst Issues Dire Warning on Oracle Stock

Why Delaying Social Security While Emptying Your 401(k) Can Slash Your Lifetime Taxes

Retiring With $1.8M in New Jersey Means an $11,400 Annual Tax Bill the Calculators Skip

Is Jeff Bezos’ New Startup An Even Bigger Idea than Amazon? He Tells CNBC it Will Drive ‘Civilizational Wealth.’

Cramer Calls Intel the “Number One Name” and “More Important Than NVIDIA.” The Stock Soars Today After a Massive Double Upgrade.

Health and Healthcare Articles

All Health and Healthcare Articles

Big Biotechs Have Short Sellers on the Run

Big Pharma Sees a Rising Tide in Short Interest

New Sickle Cell Disease Treatment Could Be a Blockbuster With $1 Billion in Sales

Meet the Newest Treatment for Autism Using Cannabidiol

Is CymaBay Therapeutics’ Liver Disease Trial Sunk?

Why NovaBay Pharma Shares Absolutely Exploded

Researchers Discover a Breakthrough Drug That May Significantly Delay Type 1 Diabetes

How ReWalk Is Capitalizing on Its Big Win

What Insys Therapeutics Gets by Filing for Chapter 11

5 ASCO Winners That Could Still More Than Double

Fake Health News Has Become So Common New Guidelines Now Help Recognize Them

The World’s Most Often Prescribed Drug Might Be Killing Us

Is InflaRx Sunk by a Midstage Skin Condition Study?

Prices for Many Very Popular Prescription Drugs Have Soared Since 2012

How ReWalk’s Exo-Suit Is Breaking the Mold for Stroke Survivors

Is Jeff Bezos’ New Startup An Even Bigger Idea than Amazon? He Tells CNBC it Will Drive ‘Civilizational Wealth.’

Cramer Calls Intel the “Number One Name” and “More Important Than NVIDIA.” The Stock Soars Today After a Massive Double Upgrade.

‘I Feel Like It’s 1999 Again.’ CNBC Analyst Issues Dire Warning on Oracle Stock

Featured Reads

Why Delaying Social Security While Emptying Your 401(k) Can Slash Your Lifetime Taxes

Retiring With $1.8M in New Jersey Means an $11,400 Annual Tax Bill the Calculators Skip